HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain
Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function.
Gespeichert in:
| Autor*in: |
Denk, Franziska [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: 336 MECHANISMS OF EGFR INHIBITORS - 2012, the journal of the International Association for the Study of Pain, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:154 ; year:2013 ; number:9 ; pages:1668-1679 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.pain.2013.05.021 |
|---|
| Katalog-ID: |
ELV027247996 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV027247996 | ||
| 003 | DE-627 | ||
| 005 | 20230623185736.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pain.2013.05.021 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013010000015.pica |
| 035 | |a (DE-627)ELV027247996 | ||
| 035 | |a (ELSEVIER)S0304-3959(13)00247-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Denk, Franziska |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| 264 | 1 | |c 2013 | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. | ||
| 650 | 7 | |a Histone deacetylase |2 Elsevier | |
| 650 | 7 | |a Histone deacetylase inhibitors |2 Elsevier | |
| 650 | 7 | |a Neuropathic pain |2 Elsevier | |
| 700 | 1 | |a Huang, Wenlong |4 oth | |
| 700 | 1 | |a Sidders, Ben |4 oth | |
| 700 | 1 | |a Bithell, Angela |4 oth | |
| 700 | 1 | |a Crow, Megan |4 oth | |
| 700 | 1 | |a Grist, John |4 oth | |
| 700 | 1 | |a Sharma, Simone |4 oth | |
| 700 | 1 | |a Ziemek, Daniel |4 oth | |
| 700 | 1 | |a Rice, Andrew S.C. |4 oth | |
| 700 | 1 | |a Buckley, Noel J. |4 oth | |
| 700 | 1 | |a McMahon, Stephen B. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Lippincott Williams and Wilkins |t 336 MECHANISMS OF EGFR INHIBITORS |d 2012 |d the journal of the International Association for the Study of Pain |g New York, NY [u.a.] |w (DE-627)ELV016061799 |
| 773 | 1 | 8 | |g volume:154 |g year:2013 |g number:9 |g pages:1668-1679 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.pain.2013.05.021 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 154 |j 2013 |e 9 |h 1668-1679 |g 12 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
f d fd |
|---|---|
| matchkey_str |
denkfranziskahuangwenlongsiddersbenbithe:2013----:dcniiosteutteeeomnohprestvtimd |
| hierarchy_sort_str |
2013 |
| publishDate |
2013 |
| allfields |
10.1016/j.pain.2013.05.021 doi GBVA2013010000015.pica (DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 540 VZ Denk, Franziska verfasserin aut HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain 2013 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier Huang, Wenlong oth Sidders, Ben oth Bithell, Angela oth Crow, Megan oth Grist, John oth Sharma, Simone oth Ziemek, Daniel oth Rice, Andrew S.C. oth Buckley, Noel J. oth McMahon, Stephen B. oth Enthalten in Lippincott Williams and Wilkins 336 MECHANISMS OF EGFR INHIBITORS 2012 the journal of the International Association for the Study of Pain New York, NY [u.a.] (DE-627)ELV016061799 volume:154 year:2013 number:9 pages:1668-1679 extent:12 https://doi.org/10.1016/j.pain.2013.05.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 154 2013 9 1668-1679 12 045F 610 |
| spelling |
10.1016/j.pain.2013.05.021 doi GBVA2013010000015.pica (DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 540 VZ Denk, Franziska verfasserin aut HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain 2013 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier Huang, Wenlong oth Sidders, Ben oth Bithell, Angela oth Crow, Megan oth Grist, John oth Sharma, Simone oth Ziemek, Daniel oth Rice, Andrew S.C. oth Buckley, Noel J. oth McMahon, Stephen B. oth Enthalten in Lippincott Williams and Wilkins 336 MECHANISMS OF EGFR INHIBITORS 2012 the journal of the International Association for the Study of Pain New York, NY [u.a.] (DE-627)ELV016061799 volume:154 year:2013 number:9 pages:1668-1679 extent:12 https://doi.org/10.1016/j.pain.2013.05.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 154 2013 9 1668-1679 12 045F 610 |
| allfields_unstemmed |
10.1016/j.pain.2013.05.021 doi GBVA2013010000015.pica (DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 540 VZ Denk, Franziska verfasserin aut HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain 2013 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier Huang, Wenlong oth Sidders, Ben oth Bithell, Angela oth Crow, Megan oth Grist, John oth Sharma, Simone oth Ziemek, Daniel oth Rice, Andrew S.C. oth Buckley, Noel J. oth McMahon, Stephen B. oth Enthalten in Lippincott Williams and Wilkins 336 MECHANISMS OF EGFR INHIBITORS 2012 the journal of the International Association for the Study of Pain New York, NY [u.a.] (DE-627)ELV016061799 volume:154 year:2013 number:9 pages:1668-1679 extent:12 https://doi.org/10.1016/j.pain.2013.05.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 154 2013 9 1668-1679 12 045F 610 |
| allfieldsGer |
10.1016/j.pain.2013.05.021 doi GBVA2013010000015.pica (DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 540 VZ Denk, Franziska verfasserin aut HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain 2013 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier Huang, Wenlong oth Sidders, Ben oth Bithell, Angela oth Crow, Megan oth Grist, John oth Sharma, Simone oth Ziemek, Daniel oth Rice, Andrew S.C. oth Buckley, Noel J. oth McMahon, Stephen B. oth Enthalten in Lippincott Williams and Wilkins 336 MECHANISMS OF EGFR INHIBITORS 2012 the journal of the International Association for the Study of Pain New York, NY [u.a.] (DE-627)ELV016061799 volume:154 year:2013 number:9 pages:1668-1679 extent:12 https://doi.org/10.1016/j.pain.2013.05.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 154 2013 9 1668-1679 12 045F 610 |
| allfieldsSound |
10.1016/j.pain.2013.05.021 doi GBVA2013010000015.pica (DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 540 VZ Denk, Franziska verfasserin aut HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain 2013 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier Huang, Wenlong oth Sidders, Ben oth Bithell, Angela oth Crow, Megan oth Grist, John oth Sharma, Simone oth Ziemek, Daniel oth Rice, Andrew S.C. oth Buckley, Noel J. oth McMahon, Stephen B. oth Enthalten in Lippincott Williams and Wilkins 336 MECHANISMS OF EGFR INHIBITORS 2012 the journal of the International Association for the Study of Pain New York, NY [u.a.] (DE-627)ELV016061799 volume:154 year:2013 number:9 pages:1668-1679 extent:12 https://doi.org/10.1016/j.pain.2013.05.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 154 2013 9 1668-1679 12 045F 610 |
| language |
English |
| source |
Enthalten in 336 MECHANISMS OF EGFR INHIBITORS New York, NY [u.a.] volume:154 year:2013 number:9 pages:1668-1679 extent:12 |
| sourceStr |
Enthalten in 336 MECHANISMS OF EGFR INHIBITORS New York, NY [u.a.] volume:154 year:2013 number:9 pages:1668-1679 extent:12 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Histone deacetylase Histone deacetylase inhibitors Neuropathic pain |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
336 MECHANISMS OF EGFR INHIBITORS |
| authorswithroles_txt_mv |
Denk, Franziska @@aut@@ Huang, Wenlong @@oth@@ Sidders, Ben @@oth@@ Bithell, Angela @@oth@@ Crow, Megan @@oth@@ Grist, John @@oth@@ Sharma, Simone @@oth@@ Ziemek, Daniel @@oth@@ Rice, Andrew S.C. @@oth@@ Buckley, Noel J. @@oth@@ McMahon, Stephen B. @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV016061799 |
| dewey-sort |
3610 |
| id |
ELV027247996 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027247996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623185736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pain.2013.05.021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013010000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027247996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0304-3959(13)00247-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Denk, Franziska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histone deacetylase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histone deacetylase inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuropathic pain</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Wenlong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sidders, Ben</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bithell, Angela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crow, Megan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grist, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Simone</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ziemek, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rice, Andrew S.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buckley, Noel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McMahon, Stephen B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Lippincott Williams and Wilkins</subfield><subfield code="t">336 MECHANISMS OF EGFR INHIBITORS</subfield><subfield code="d">2012</subfield><subfield code="d">the journal of the International Association for the Study of Pain</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV016061799</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1668-1679</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pain.2013.05.021</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2013</subfield><subfield code="e">9</subfield><subfield code="h">1668-1679</subfield><subfield code="g">12</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Denk, Franziska |
| spellingShingle |
Denk, Franziska ddc 610 ddc 570 Elsevier Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| authorStr |
Denk, Franziska |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV016061799 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 570 540 VZ HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain Elsevier |
| topic |
ddc 610 ddc 570 Elsevier Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain |
| topic_unstemmed |
ddc 610 ddc 570 Elsevier Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain |
| topic_browse |
ddc 610 ddc 570 Elsevier Histone deacetylase Elsevier Histone deacetylase inhibitors Elsevier Neuropathic pain |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
w h wh b s bs a b ab m c mc j g jg s s ss d z dz a s r as asr n j b nj njb s b m sb sbm |
| hierarchy_parent_title |
336 MECHANISMS OF EGFR INHIBITORS |
| hierarchy_parent_id |
ELV016061799 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
336 MECHANISMS OF EGFR INHIBITORS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV016061799 |
| title |
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| ctrlnum |
(DE-627)ELV027247996 (ELSEVIER)S0304-3959(13)00247-9 |
| title_full |
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| author_sort |
Denk, Franziska |
| journal |
336 MECHANISMS OF EGFR INHIBITORS |
| journalStr |
336 MECHANISMS OF EGFR INHIBITORS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
1668 |
| author_browse |
Denk, Franziska |
| container_volume |
154 |
| physical |
12 |
| class |
610 610 DE-600 610 VZ 570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Denk, Franziska |
| doi_str_mv |
10.1016/j.pain.2013.05.021 |
| dewey-full |
610 570 540 |
| title_sort |
hdac inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| title_auth |
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| abstract |
Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. |
| abstractGer |
Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. |
| abstract_unstemmed |
Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
9 |
| title_short |
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain |
| url |
https://doi.org/10.1016/j.pain.2013.05.021 |
| remote_bool |
true |
| author2 |
Huang, Wenlong Sidders, Ben Bithell, Angela Crow, Megan Grist, John Sharma, Simone Ziemek, Daniel Rice, Andrew S.C. Buckley, Noel J. McMahon, Stephen B. |
| author2Str |
Huang, Wenlong Sidders, Ben Bithell, Angela Crow, Megan Grist, John Sharma, Simone Ziemek, Daniel Rice, Andrew S.C. Buckley, Noel J. McMahon, Stephen B. |
| ppnlink |
ELV016061799 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.pain.2013.05.021 |
| up_date |
2024-07-06T21:24:01.208Z |
| _version_ |
1803866384587816960 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027247996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623185736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pain.2013.05.021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013010000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027247996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0304-3959(13)00247-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Denk, Franziska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histone deacetylase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histone deacetylase inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuropathic pain</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Wenlong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sidders, Ben</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bithell, Angela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crow, Megan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grist, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Simone</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ziemek, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rice, Andrew S.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buckley, Noel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McMahon, Stephen B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Lippincott Williams and Wilkins</subfield><subfield code="t">336 MECHANISMS OF EGFR INHIBITORS</subfield><subfield code="d">2012</subfield><subfield code="d">the journal of the International Association for the Study of Pain</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV016061799</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1668-1679</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pain.2013.05.021</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2013</subfield><subfield code="e">9</subfield><subfield code="h">1668-1679</subfield><subfield code="g">12</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4003897 |